PanGen Biotech Inc. (KOSDAQ:222110)

PanGen Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9,002	1,430	45.4	838.28	8,901	8,139
Short-Term Investments	8,046	10,002	149.24	2	15,199	10,550
Cash & Short-Term Investments	17,048	11,432	194.64	840.28	24,100	18,689
Cash Growth	224.91%	5773.48%	-76.84%	-96.51%	28.95%	-23.29%
Accounts Receivable	2,099	2,959	2,208	689.81	1,089	535.34
Other Receivables	47.28	51.8	8.54	221.29	241.03	176.87
Receivables	2,247	3,261	2,330	974.1	1,393	775.21
Inventory	7,610	6,001	6,925	6,630	4,373	3,764
Prepaid Expenses	54.61	53.96	58.91	71.41	21.39	15.49
Other Current Assets	630.12	20.35	333.62	60.91	1,267	847.87
Total Current Assets	27,589	20,768	9,843	8,576	31,154	24,092
Property, Plant & Equipment	5,738	5,805	6,240	6,608	6,748	6,029
Long-Term Investments	-0	0	0	0	-0	0
Other Intangible Assets	730.19	785.13	879.93	269.63	313.41	271.58
Long-Term Deferred Charges	2,294	2,622	3,278	3,933	4,589	5,244
Other Long-Term Assets	530.99	564.14	501.5	1,287	473.47	673.02
Total Assets	36,883	30,545	20,741	20,674	43,277	36,309
Accounts Payable	195.42	423.33	298.82	255.48	381.91	296.57
Short-Term Debt	885.59	816.3	2,014	-	18,692	18,399
Current Portion of Leases	1.33	1.84	1.69	1.56	1.43	-
Other Current Liabilities	3,438	1,657	3,396	872.49	811.14	1,395
Total Current Liabilities	4,521	2,899	5,711	1,130	19,886	20,091
Long-Term Leases	-	0.39	2.24	3.93	5.49	-
Other Long-Term Liabilities	-0	30	30	206.41	116.22	77.31
Total Liabilities	7,388	5,636	8,175	3,454	22,179	22,098
Common Stock	6,747	6,449	5,339	5,339	5,336	4,821
Additional Paid-In Capital	70,379	67,712	57,402	57,402	57,371	47,840
Retained Earnings	-48,333	-49,953	-50,876	-46,210	-42,062	-38,680
Comprehensive Income & Other	700.82	700.82	700.82	688.64	452.86	229.89
Total Common Equity	29,494	24,909	12,566	17,219	21,098	14,211
Shareholders' Equity	29,494	24,909	12,566	17,219	21,098	14,211
Total Liabilities & Equity	36,883	30,545	20,741	20,674	43,277	36,309
Total Debt	886.92	818.54	2,018	5.49	18,699	18,399
Net Cash (Debt)	16,161	10,614	-1,823	834.79	5,402	290.4
Net Cash Growth	428.50%	-	-	-84.55%	1760.05%	-95.84%
Net Cash Per Share	1302.43	927.83	-170.60	78.21	528.69	30.13
Filing Date Shares Outstanding	13.2	12.9	10.68	10.68	10.67	9.64
Total Common Shares Outstanding	13.2	12.9	10.68	10.68	10.67	9.64
Working Capital	23,068	17,869	4,132	7,447	11,267	4,001
Book Value Per Share	2233.82	1931.18	1176.85	1612.67	1976.95	1473.91
Tangible Book Value	28,764	24,124	11,686	16,950	20,784	13,940
Tangible Book Value Per Share	2178.52	1870.31	1094.44	1587.42	1947.58	1445.75
Land	1,174	1,174	1,174	1,174	1,174	1,004
Buildings	3,909	3,909	3,909	3,909	3,909	3,456
Machinery	11,944	11,766	11,545	11,434	10,381	9,811
Construction In Progress	-	-	125.36	-	332.66	1.11

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.